Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
January 11, 2011
Patent Application Number
10770639
Date Filed
February 2, 2004
Patent Primary Examiner
Patent abstract
Disclosed are methods of treating subjects having disorders or conditions characterized by an unwanted immune response including administering an effective amount of an early activation molecule agonist, antagonist or depletor, to the subject. Human monoclonal antibodies specific to the early activation molecules, and methods of use, are also disclosed.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
